PC3 - Perinatal Substance Use Disorders: Impact on Women and Infants

Title: PC3 - Perinatal Substance Use Disorders: Impact on Women and Infants

Disciplines: Childbearing (CB), Newborn Care (N)

Learning Objectives:
  • 1. Describe the factors associated with the surge of perinatal substance use disorders and the epidemic of opioid dependence among pregnant women.
  • Discuss the consequences of substance abuse on maternal and neonatal outcomes and the impact on families and communities.
  • Formulate multidisciplinary strategies for the detection, support and treatment of pregnant women with a substance abuse disorder.

    • Submission Description:
    This session will cover perinatal substance use disorders and effects on pregnancy and neonatal outcomes. Emphasis will be on the risks and benefits of long term opioid use for chronic pain and/or opioid dependence in pregnancy and the postpartum period as more women become pregnant while on long acting opioids. Effects of in-utero opioid exposure on fetal/infant development and benefits of breastfeeding to reduce neonatal abstinence syndrome will be discussed. Future considerations for opioid detoxification in pregnancy will be explored.
    Saturday, June 13, 2015: 8:00 AM-12:00 PM
    Room 104B (Long Beach Convention Center)
    Presenting Author:
    Ursula A. Pritham, PhD, WHNP-BC, FNP-BC
    Moderator:
    Tiffany M. Montgomery, MSN, RNC-OB, C-EFM
    << Previous Session | Next Session >>
    The Association of Women's Health, Obstetric and Neonatal Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.